Guwahati, Feb 5: Sun Pharmaceutical Industries Limited, India’s largest and the world’s fourth-largest pharmaceutical company, is set to invest over Rs 500 crore in Assam to establish a new drug formulation manufacturing unit, Chief Secretary Ravi Kota announced.

Senior company officials, including Senior Vice President Rahul Awasthi and Associate Vice President Ranjit Mohapatra, met Kota on Wednesday to review the proposal. The project, planned in two phases, will cater to the Indian market and is expected to generate direct employment for more than 500 people once operational.

Discussions during the meeting included land acquisition, water and power supply, connectivity, and access to skilled workers. The company highlighted its commitment to sustainable practices, including efficient water usage, renewable energy adoption, and responsible waste management, aligning with environmental standards.

“This meeting underscores the Assam government’s commitment to attracting investors for job creation, inclusive growth, and economic development,” Kota said in an X post. Sun Pharma currently operates over 40 facilities across five continents and serves more than 100 countries.